Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission

PLoS ONE(2020)10.1371/journal.pone.0233693Source: DataRank Database

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: goldTopics (73)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Mary‐Ann Davies ORCID,Karl‐Günter Technau ORCID,Geoffrey Fatti ORCID,Helena Rabie ORCID,Frank Tanser ORCID

Live enrichment

PubMed:32469985 PMC:PMC7259572 OpenAlex:https://openalex.org/W3028698724

National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health

Grant: U01AI069924

National Institutes of Health

Grant: 5U01AI069924-13

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233693&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233693&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0233693

journalhttps://doi.org/10.1371/journal.pone.0233693

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32469985

Fields of Study

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV-related health complications and treatments03 medical and health sciences0302 clinical medicineAdolescentAdultAlkynesAnti-Retroviral AgentsBenzoxazinesChildChild, PreschoolCyclopropanesFemaleHIV InfectionsHIV-1HumansInfectious Disease Transmission, VerticalMaleRisk Factors

MeSH Terms

AdolescentAdultAlkynesChildChild, PreschoolCyclopropanesFemaleHumansMaleRisk FactorsHIV-1HIV InfectionsInfectious Disease Transmission, VerticalAnti-Retroviral AgentsBenzoxazines

Keywords

EfavirenzAntiretroviral therapyMedicineTransmission (telecommunications)Human immunodeficiency virus (HIV)VirologyPediatricsViral loadComputer scienceTelecommunicationsAdultCyclopropanesMaleAdolescentScience610HIV InfectionsRisk Factors616Immune suppressionHumansChildChildrenQProtease inhibitor therapyRHIVInfectious Disease Transmission, VerticalBenzoxazinesMedical risk factorsAnti-Retroviral AgentsAlkynesChild, PreschoolHIV-1FemaleInfantsA300 - Clinical medicineResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being